AstraZeneca PLC Dividend History (AZN)
🤑 AstraZeneca PLC has distributed a total of 43 dividends from 2003 to 2024
📈 During this 21 period their dividend has seen a 96.08% increase in the payout amount
About AstraZeneca PLC
AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Established in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group, the company has grown to become a major player in the pharmaceutical industry. As of 2023, Pascal Soriot serves as the CEO, a position he has held since 2012, helping drive innovation and growth within the company. Headquartered in Cambridge, UK, AstraZeneca operates in over 100 countries, with a significant commitment to research and development, boasting several R&D centers worldwide. In recent years, the company has gained attention for its role in developing a COVID-19 vaccine and its ongoing efforts in oncological research. AstraZeneca reported a revenue of approximately $37.4 billion in 2022, reflecting its global impact on healthcare and its continuous push towards addressing unmet medical needs.
The global RNA-targeted small molecules market is projected to grow from USD 2,453.5 million in 2024 to USD 4,311.7 million by 2034, driven by increasing investments in R&D and the transformative potential of these therapies in addressing genetic and chronic diseases.
GlobeNewswire Inc. · Published on Thu Dec 05 2024Sanofi, a global pharmaceutical company, has significantly increased its investments in Beijing E-Town over the past three decades, reflecting the area's favorable business environment. The article highlights the exceptional services and support provided by E-Town, which have earned the confidence of multinational corporations.
GlobeNewswire Inc. · Published on Thu Dec 05 2024The report discusses emerging therapies for non-cystic fibrosis bronchiectasis, a chronic lung condition, including Brensocatib and HSK31858, which are in advanced clinical trials and show promise in reducing inflammation and improving patient outcomes.
GlobeNewswire Inc. · Published on Thu Nov 28 2024Previous Payouts (43)
The most recent dividend AstraZeneca PLC paid out was on September 9, 2024 (88 days ago) for $0.5 per share
Pay Date | Amount |
---|---|
September 9, 2024 | $0.5 |
March 25, 2024 | $0.985 |
September 11, 2023 | $0.465 |
March 27, 2023 | $0.985 |
September 12, 2022 | $0.465 |
March 28, 2022 | $0.985 |
September 13, 2021 | $0.45 |
March 29, 2021 | $0.95 |
September 14, 2020 | $0.45 |
March 30, 2020 | $0.95 |
September 9, 2019 | $0.45 |
March 27, 2019 | $0.95 |
September 10, 2018 | $0.45 |
March 19, 2018 | $0.95 |
September 11, 2017 | $0.45 |
March 20, 2017 | $0.95 |
September 12, 2016 | $0.45 |
March 21, 2016 | $0.95 |
September 14, 2015 | $0.45 |
March 23, 2015 | $1.9 |
September 15, 2014 | $0.9 |
March 24, 2014 | $1.9 |
September 16, 2013 | $0.9 |
March 18, 2013 | $1.9 |
September 10, 2012 | $0.9 |
March 19, 2012 | $1.95 |
September 12, 2011 | $0.85 |
March 14, 2011 | $1.85 |
September 13, 2010 | $0.7 |
March 15, 2010 | $1.71 |
September 14, 2009 | $0.59 |
March 16, 2009 | $1.5 |
September 15, 2008 | $0.55 |
March 17, 2008 | $1.35 |
September 17, 2007 | $0.52 |
March 19, 2007 | $1.23 |
September 18, 2006 | $0.49 |
March 20, 2006 | $0.92 |
September 19, 2005 | $0.38 |
March 21, 2005 | $0.645 |
September 20, 2004 | $0.295 |
April 6, 2004 | $0.54 |
October 6, 2003 | $0.255 |
Dividend data last updated Fri, 06 Dec 2024 19:00:16 GMT UTC